Risperidone versus haloperidol on secondary memory: Can newer medications aid learning?

Schizophrenia Bulletin

Volumn 25, Issue 2, 1999, Pages 223-232

  Kern, Robert S ^a,b   Green, Michael F ^a   Marshall Jr , Barringer D ^a   Wirshing, William C ^a   Wirshing, Donna ^a   McGurk, Susan R ^a   Marder, Stephen R ^a   Mintz, Jim ^a  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

California Verbal Learning Test (CVLT); Haloperidol; Memory; Risperidone; Verbal learning

Indexed keywords

BENZATROPINE; HALOPERIDOL; NEUROLEPTIC AGENT; PLACEBO; RISPERIDONE;

ADULT; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG RESISTANCE; FEMALE; HUMAN; LEARNING; LEARNING TEST; LONG TERM MEMORY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECALL; RECOGNITION; REVIEW; SCHIZOPHRENIA; WORKING MEMORY;

EID: 0033017428     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a033375     Document Type: Review

References (40)

1. Atkinson, R.C., and Shiffren, R.M. Human memory: A proposal system and its control processes. In: Spencer, K.W., ed. The Psychology of Learning and Motivation: Advances in Research and Theory, vol. 2. New York, NY: Academic Press, 1968.
2. Bassuk, E.L., and Schoonover, S.C. The Practitioner's Guide to Psychoactive Drugs, 2nd ed. New York, NY: Plenum Press, 1983.
3. Bellack, A.S.; Sayers, M.; Mueser, K.; and Bennett, M. Evaluation of social problem solving in schizophrenia. Journal of Abnormal Psychology, 103:371-378, 1994.
4. Buchanan, R.W.; Holstein, C.; and Breier, A. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biological Psychiatry, 36:717-725, 1994.
5. Calev, A.; Korin, Y.; Kugelmass, S.; and Lerer, B. Performance of chronic schizophrenics on matched word and design recall tasks. Biological Psychiatry, 22:699-709, 1987.
6. Calev, A.; Venables, P.H.; and Monk, A.F. Evidence for distinct verbal memory pathologies in severely and mildly disturbed schizophrenics. Schizophrenia Bulletin, 9:243-264, 1983.
7. Cassens, G.; Inglis, A.K.; Appelbaum, P.S.; and Gutheil, T.G. Neuroleptics: Effects on neuropsychological function in chronic schizophrenic patients. Schizophrenia Bulletin, 16:477-499, 1990.
8. Corrigan, P.W.; Green, M.F.; and Toomey, R. Cognitive correlates to social cue perception in schizophrenia. Psychiatry Research, 53:141-151, 1994a.
9. Corrigan, P.W.; Wallace, C.J.; Schade, M.I.; and Green, M.F. Cognitive dysfunctions and psychosocial skill learning in schizophrenia. Behavior Therapy, 25:5-15, 1994b.
10. Delis, D.C.; Kramer, J.H.; Kaplan, E.; and Ober, B.A. California Verbal Learning Test - Manual. San Antonio, TX: Psychological Corp, 1987.
11. Gold, J.M.; Goldberg, T.E.; Kleinman, J.E.; and Weinberger, D.R. The impact of symptomatic state and pharmacological treatment on cognitive functioning of patients with schizophrenia and mood disorders. In: Mohr, E., and Brouwers, P., eds. Handbook of Clinical Trials: The Neurobehavioral Approach. Amsterdam, The Netherlands: Swets & Zeitlinger, 1991. pp. 185-214.
12. Gold, J.M.; Randolph, C.; Carpenter, C.J.; Goldberg, T.E.; and Weinberger, D.R. Forms of memory failure in schizophrenia. Journal of Abnormal Psychology, 101:487-494, 1992.
13. Goldberg, T.E.; Greenberg, R.D.; Griffin, S.J.; Gold, J.M.; Kleinman, J.E.; Pickar, D.; Schulz, S.C.; and Weinberger, D.R. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. British Journal of Psychiatry, 162:43-48, 1993.
14. Goldman, R.S.; Axelrod, B.N.; Tandon, R.; Ribeiro, S.C.M.; Craig, K.; and Berent, S. Neuropsychological prediction of treatment efficacy and one-year outcome in schizophrenia. Psychopathology, 126:122-126, 1993.
15. Goldman-Rakic, P.S. Circuitry of primate prefrontal cortex and regulation of behavior by representational knowledge. In: Plum, F., and Mountcastle, V., eds. Handbook of Physiology - The Nervous System V. Bethesda, MD: American Physiological Society, 1987. pp. 373-417.
16. Green, M.F. What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153:321-330, 1996.
17. Green, M.F.; Marshall, B.D., Jr.; Wirshing, W.C.; Ames, D.; Marder, S.R.; McGurk, S.; Kern, R.S.; and Mintz, J. Does risperidone improve verbal working memory in treatment-resistant schizophrenia? American Journal of Psychiatry, 154:799-804, 1997.
18. Green, M.F., and Nuechterlein, K.H. Should schizophrenia be treated as a neurocognitive disorder? Schizophrenia Bulletin, 25(2):309-319, 1999.
19. Haggar, C.; Buckley, P.; Kenny, J.T.; Friedman, L.; Ubogy, D.; and Meltzer, H.Y. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biological Psychiatry, 34:702-712, 1993.
20. Hoff, A.L.; Faustman, W.O.; Wieneke, M.; Espinoza, S.; Costa, M.; Wolkowitz, O.; and Csernansky, J.G. The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment refractory state hospital schizophrenic inpatients. Neuropsychopharmacology, 15:361-369, 1996.
21. Kane, J.; Honigfield, G.; Singer, J.; Meltzer, H.; and Group, C.C.S. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45:789-796, 1988.
22. Keefe, R.S.E.; Silva, S.G.; Perkins, D.O.; and Lieberman, J.A. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis. Schizophrenia Bulletin, 25(2):201-222, 1999.
23. Kern, R.S.; Green, M.F.; and Satz, P. Neuropsychological predictors of skills training for chronic psychiatric patients. Psychiatry Research, 43:223-230, 1992.
24. Koh, S.D., and Kayton, L. Memorization of "unrelated" word strings by young nonpsychotic schizophrenics. Journal of Abnormal Psychology, 33:14-22, 1974.
25. Koh, S.D.; Kayton, L.; and Berry, R. Mnemonic organization in young nonpsychotic schizophrenics. Journal of Abnormal Psychology, 81:299-310, 1973.
26. McEntee, W., and Crook, T. Serotonin, memory, and aging. Psychopharmacology, 103:143-149, 1991.
27. Medalia, A.; Gold, J.; and Mirriam, A. The effects of neuroleptics on neuropsychological test results of schizophrenics. Archives of Clinical Neuropsychology, 3:249-271, 1988.
28. Mortimer, A.M. Cognitive function in schizophrenia - Do neuroleptics make a difference? Pharmacology, Biochemistry and Behavior, 56:789-795, 1997.
29. Mueser, K.T.; Bellack, A.S.; Douglas, M.S.; and Wade, J.H. Prediction of social skill acquisition in schizophrenic and major affective disorder patients from memory and symptomatology. Psychiatry Research, 37:281-296, 1991.
30. Overall, J.E., and Gorham, D.R. The Brief Psychiatric Rating Scale. Psychological Reports, 10:799-812, 1962.
31. Paulsen, J.S.; Heaton, R.K.; Sadek, J.R.; Perry, W.; Delis, D.C.; Braff, D.; Kuck, J.; Zisook, S.; and Jeste, D.V. The nature of learning and memory impairments in schizophrenia. Journal of the International Neuropsychological Society, 1:88-99, 1995.
32. Perlick, D.; Stastny, P.; Katz, I.; Mayer, M.; and Mattis, S. Memory deficits and anticholinergic levels in chronic schizophrenia. American Journal of Psychiatry, 143:230-232, 1986.
33. Petri, H.L., and Mishkin, M. Behaviorism, cognativism and the neuropsychology of memory. American Scientist, 82:30-37, 1994.
34. Saykin, A.J.; Gur, R.C.; Gur, R.E.; Mozley, P.D.; Mozley, L.H.; Resnick, S.M.; Kester, D.B.; and Stafiniak, P. Neuropsychological function in schizophrenia: Selective impairment in memory and learning. Archives of General Psychiatry, 48:618-624, 1991.
35. Spitzer, R.L.; Williams, J.B.W.; Gibbon, M.; and First, M.B. Structured Clinical Interview for DSM-III-R, Patient Edition (SCID-P, Version 1.0). Washington, DC: American Psychiatric Press, 1990.
36. Strek, K.F.; Spencer, K.R.; and DeNoble, V.J. Manipulation of serotonin protects against an hypoxia-induced deficit of a passive avoidance response in rats. Pharmacology, Biochemistry, and Behavior, 33:241-244, 1989.
37. Thompson, R.F. Brain substrates of learning and memory. In: Boll, T., and Bryant, B.K., eds. Clinical Neuropsychology and Brain Function: Research, Measurement, and Practice. Washington, DC: American Psychological Association, 1988.
38. Tune, L.E.; Strauss, M.E.; Lew, M.F.; Breitlinger, E.; and Coyle, J.T. Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients. American Journal of Psychiatry, 139:187-190, 1982.
39. Ventura, J.; Green, M.F.; Shaner, A.; and Liberman, R.P. Training and quality assurance with the Brief Psychiatric Rating Scale: "The drift busters." International Journal of Methods in Psychiatric Research, 3:221-224, 1993.
40. Wickelgren, W.A. Human learning and memory. Annual Review of Psychology, 32:21-52, 1981.